Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study.
暂无分享,去创建一个
E Monsó | J. Sunyer | J. Garcia-Aymerich | J. Antó | J. Escarrabill | E. Monso | R. Marrades | J Sunyer | J M Antó | M. Felez | J Garcia-Aymerich | R M Marrades | J Escarrabill | M A Félez
[1] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[2] N. Anthonisen. Smoking, lung function, and mortality , 2000, Thorax.
[3] R. Phillips,et al. A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. , 1998, The American journal of medicine.
[4] J C Yernault,et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.
[5] J. Escarrabill,et al. DOMICILIARY OXYGEN THERAPY , 1985, The Lancet.
[6] R. Irwin,et al. Chronic obstructive pulmonary disease , 1998, The Lancet.
[7] Phillips Yy,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.
[8] J. Collet,et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.
[9] N. Pearce,et al. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. , 1990, Thorax.
[10] M. Decramer,et al. Muscle weakness is related to utilization of health care resources in COPD patients. , 1997, The European respiratory journal.
[11] Gordon H Guyatt,et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.
[12] D. Górecka,et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.
[13] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[14] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[15] R. Albert. Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? No. , 1997, American journal of respiratory and critical care medicine.
[16] A. Detsky,et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. , 1994, Archives of internal medicine.
[17] K. Nichol,et al. Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease , 1999, Annals of Internal Medicine.
[18] P. Lange,et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.
[19] J. G. Douglas,et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.
[20] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[21] J. Fagon,et al. Severe exacerbations of COPD patients: the role of pulmonary infections. , 1996, Seminars in respiratory infections.
[22] N. Pearce,et al. PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY , 1989, The Lancet.
[23] J. Garcia-Aymerich,et al. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). , 2000, The European respiratory journal.
[24] L Goldman,et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.
[25] E. Weitzenblum,et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[26] J. Vestbo,et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[27] J. Schwartz,et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. , 1997, The European respiratory journal.